HUP0003511A3 - Hepatitis b virus polypeptides - Google Patents
Hepatitis b virus polypeptidesInfo
- Publication number
- HUP0003511A3 HUP0003511A3 HU0003511A HUP0003511A HUP0003511A3 HU P0003511 A3 HUP0003511 A3 HU P0003511A3 HU 0003511 A HU0003511 A HU 0003511A HU P0003511 A HUP0003511 A HU P0003511A HU P0003511 A3 HUP0003511 A3 HU P0003511A3
- Authority
- HU
- Hungary
- Prior art keywords
- hepatitis
- virus polypeptides
- polypeptides
- virus
- Prior art date
Links
- 241000700721 Hepatitis B virus Species 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- Public Health (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9720033.1A GB9720033D0 (en) | 1997-09-19 | 1997-09-19 | Hepatitis B virus polypeptides |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0003511A2 HUP0003511A2 (hu) | 2001-02-28 |
| HUP0003511A3 true HUP0003511A3 (en) | 2003-08-28 |
Family
ID=10819394
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0003511A HUP0003511A3 (en) | 1997-09-19 | 1998-09-21 | Hepatitis b virus polypeptides |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20040258709A1 (hu) |
| EP (1) | EP1015593B1 (hu) |
| JP (1) | JP2001517447A (hu) |
| KR (1) | KR100637282B1 (hu) |
| AT (1) | ATE241013T1 (hu) |
| AU (1) | AU751646B2 (hu) |
| CA (1) | CA2304255C (hu) |
| CZ (1) | CZ297131B6 (hu) |
| DE (1) | DE69814884T2 (hu) |
| ES (1) | ES2199460T3 (hu) |
| GB (1) | GB9720033D0 (hu) |
| HU (1) | HUP0003511A3 (hu) |
| NO (1) | NO20001397L (hu) |
| PL (1) | PL195242B1 (hu) |
| WO (1) | WO1999015671A1 (hu) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0009470D0 (en) * | 2000-04-17 | 2000-06-07 | Univ Southampton | Materials and methods relating to immune responses to fusion proteins |
| EP1281761A1 (en) | 2001-07-27 | 2003-02-05 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Hepatitis B virus pre-S1 derived synthetic polypeptides and their use thereof. |
| WO2005000346A1 (en) * | 2003-06-23 | 2005-01-06 | Baxter International Inc. | Carrier proteins for vaccines |
| CN100537762C (zh) * | 2004-06-24 | 2009-09-09 | 中国人民解放军军事医学科学院野战输血研究所 | 一种嵌合型病毒样颗粒疫苗载体蛋白及其制备方法与应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10299017I2 (de) * | 1987-06-22 | 2005-05-25 | Medeva Holdings Bv | Hepatitis-B-Oberfl{chenantigen enthaltendes Peptid. |
| EP0389983A3 (en) * | 1989-03-31 | 1991-01-16 | Abbott Laboratories | Monoclonal antibodies to pres2 and pres1 polypeptides of the hepatitis b viral envelope |
| WO1994001132A1 (en) * | 1992-07-07 | 1994-01-20 | Merck & Co., Inc. | VACCINE COMPRISING MIXED preS1+preS2+S AND CORE PARTICLE |
| ATE174628T1 (de) * | 1992-07-31 | 1999-01-15 | Medeva Holdings Bv | Expression rekombinanter fusionsproteine in attenuierten bakterien |
| AU7235794A (en) * | 1993-07-30 | 1995-02-28 | Medeva Holdings B.V. | Vaccine compositions |
| GB9401795D0 (en) * | 1994-01-31 | 1994-03-23 | Medeva Holdings Bv | Vaccines |
-
1997
- 1997-09-19 GB GBGB9720033.1A patent/GB9720033D0/en not_active Ceased
-
1998
- 1998-09-21 AU AU91744/98A patent/AU751646B2/en not_active Ceased
- 1998-09-21 DE DE69814884T patent/DE69814884T2/de not_active Expired - Fee Related
- 1998-09-21 JP JP2000512962A patent/JP2001517447A/ja active Pending
- 1998-09-21 HU HU0003511A patent/HUP0003511A3/hu unknown
- 1998-09-21 WO PCT/GB1998/002852 patent/WO1999015671A1/en active IP Right Grant
- 1998-09-21 CZ CZ20000978A patent/CZ297131B6/cs not_active IP Right Cessation
- 1998-09-21 AT AT98944071T patent/ATE241013T1/de not_active IP Right Cessation
- 1998-09-21 EP EP98944071A patent/EP1015593B1/en not_active Expired - Lifetime
- 1998-09-21 PL PL98339366A patent/PL195242B1/pl not_active IP Right Cessation
- 1998-09-21 ES ES98944071T patent/ES2199460T3/es not_active Expired - Lifetime
- 1998-09-21 CA CA002304255A patent/CA2304255C/en not_active Expired - Fee Related
- 1998-09-21 KR KR1020007002945A patent/KR100637282B1/ko not_active IP Right Cessation
-
2000
- 2000-03-17 NO NO20001397A patent/NO20001397L/no not_active Application Discontinuation
-
2004
- 2004-07-15 US US10/892,018 patent/US20040258709A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0003511A2 (hu) | 2001-02-28 |
| DE69814884T2 (de) | 2004-03-11 |
| ES2199460T3 (es) | 2004-02-16 |
| KR100637282B1 (ko) | 2006-10-24 |
| CA2304255A1 (en) | 1999-04-01 |
| NO20001397D0 (no) | 2000-03-17 |
| CZ2000978A3 (cs) | 2001-01-17 |
| NO20001397L (no) | 2000-05-05 |
| PL195242B1 (pl) | 2007-08-31 |
| PL339366A1 (en) | 2000-12-18 |
| US20040258709A1 (en) | 2004-12-23 |
| AU9174498A (en) | 1999-04-12 |
| CZ297131B6 (cs) | 2006-09-13 |
| AU751646B2 (en) | 2002-08-22 |
| EP1015593A1 (en) | 2000-07-05 |
| ATE241013T1 (de) | 2003-06-15 |
| JP2001517447A (ja) | 2001-10-09 |
| EP1015593B1 (en) | 2003-05-21 |
| KR20010024176A (ko) | 2001-03-26 |
| CA2304255C (en) | 2009-07-07 |
| WO1999015671A1 (en) | 1999-04-01 |
| DE69814884D1 (de) | 2003-06-26 |
| GB9720033D0 (en) | 1997-11-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69940817D1 (en) | Hepatitis c tripeptide inhibitoren | |
| PT1090128E (pt) | Polipéptidos dependentes da vitamina k modificados | |
| ZA9810716B (en) | Novel polypeptides | |
| DE69617211D1 (en) | Hepatitis b impfstoff | |
| AU2064297A (en) | Hepatitis c virus ribozymes | |
| IL141011A (en) | Hepatitis c inhibitor peptides | |
| ZA9811316B (en) | Novel hepatitis C virus NS5B protein | |
| GB9718110D0 (en) | Peptides | |
| EP1113777A4 (en) | NOVEL HEPATITIS C VIRUS PEPTIDES AND USES THEREOF | |
| GB9723478D0 (en) | Magnetrons | |
| HUP0003511A3 (en) | Hepatitis b virus polypeptides | |
| HU9800113D0 (en) | Transgenic virus | |
| IL139269A0 (en) | Hepatitis vaccine | |
| GB9700154D0 (en) | Peptides | |
| ZA984322B (en) | Sucrose-binding proteins | |
| GB9707221D0 (en) | Hepatitis B virus mutations | |
| EP0996457A4 (en) | PEPTIDES RELEASERS OF F.S.H. | |
| EP0917878A4 (en) | REMEDIES FOR HEPATITIS | |
| EP1140155A4 (en) | IMPROVED RECOMBINATION HEPATITIS B ENVELOPE ANTIGEN | |
| HUP0003971A2 (en) | Compact epstein-barr virus replicons | |
| GB9806525D0 (en) | Recombinant virus | |
| GB9721182D0 (en) | Hepatitis C receptor protein | |
| GB9813560D0 (en) | Hepatitis C Receptor Protein | |
| HU0400424D0 (en) | Hepatitis virus vaccines | |
| GB9420956D0 (en) | Virus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD9A | Lapse of provisional protection due to non-payment of fees |